- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
2-8℃
- 保质期:
见包装
- 英文名:
Pseudoginsenoside F11
- 库存:
大量现货
- 供应商:
上海研谨生物
- CAS号:
69884-00-0
- 规格:
20mg
拟人参皂苷F11
分析标准品,HPLC≥98%
Pseudoginsenoside F11
CAS号:69884-00-0
分子式:C42H72O14
分子量:801.01
MDL:MFCD00803938
|
货号 |
规格/参数/品牌 |
价格 |
货期 |
|
YJ-B20902-20mg |
分析标准品,HPLC≥98% |
¥700.00 |
现货 |
产品介绍
沸点:889.5 ℃ at 760 mmHg
溶解性:DMSO:20mg/ml
敏感性:对空气和光敏感
储存条件:2-8℃
注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验参考文献(11篇)
11. [IF=14.5] Ke Zhang et al."Triple three-dimensional MS/MS spectrum facilitates quantitative ginsenosides-targeted sub-metabolome characterization in notoginseng."Acta Pharmaceutica Sinica B".2024 May;:
10. [IF=2.9] Bai Yuxin et al."UHPLC–HRMS based saponins profiling of three morphological regions in American ginseng (Panax quinquefolium L.) and their correlation with the antioxidant activity."FOOD SCIENCE AND BIOTECHNOLOGY.2023 Nov;:1-12
9. [IF=8.8] Shiying Luo et al."Spatial metabolomics method to reveal differential metabolomes in microregions of Panax quinquefolius roots by using ultra-performance liquid chromatography quadrupole/time of flight-mass spectrometry and desorption electrospray ionizati
8. [IF=3.007] Xuanming Zhang et al."LC-MS analysis of ginsenosides in different parts of Panax quinquefolius and their potential for coronary disease improvement."PLANTA MEDICA.2023 Mar;0(AAM):
7. [IF=5.988] Dong Rong et al."Identification of key pharmacodynamic markers of American ginseng against heart failure based on metabolomics and zebrafish model."Frontiers in Pharmacology.2022 Oct;0:4168
6. [IF=1.885] Guo Na et al."Comparison of the Saponins in Three Processed American Ginseng Products by Ultra-High Performance Liquid Chromatography-Quadrupole Orbitrap Tandem Mass Spectrometry and Multivariate Statistical Analysis."International Journal of Analytical Ch
5. [IF=5.811] He Zhang et al."Prevention Effect of Protopanaxadiol-Type Saponins Saponins and Protopanaxatriol-Type Saponins on Myelosuppression Mice Induced by Cyclophosphamide.."Frontiers in Pharmacology. 2022 Apr;13:845034-845034
4. [IF=2.419] Yinping Jin et al."Dynamic changes of ginsenosides in Panax quinquefolius fruit at different development stages measured by UHPLC-Orbitrap MS."Rapid Communications In Mass Spectrometry. 2022 Feb 17
3. [IF=3.361] Yuhao Zhang et al."An integrated approach for structural characterization of Gui Ling Ji by traveling wave ion mobility mass spectrometry and molecular network."Rsc Adv. 2021 Apr;11(26):15546-15556
2. Joo, Kyung-Mi, et al. "Pharmacokinetic study of ginsenoside Re with pure ginsenoside Re and ginseng berry extracts in mouse using ultra performance liquid chromatography/mass spectrometric method." Journal of pharmaceutical and biomedical analysis 51.1 (20
1. 高松红,杨迪,李忠起,郑飞,JEON You-Jin,戴雨霖.快速高分辨液相色谱-质谱联用技术分析2型糖尿病大鼠口服四君子汤的药代动力学[J].应用化学,2021,38(03):315-322.
病例对照研究在制订计划和执行时应注意以下问题: (1)主要假设的说明是否清楚、简明而且可以检验? (2)疾病与暴露变量的定义清楚、明确否? (3)是否拟探索剂量反应关系和多个危险因素的联合作用? (4)为解答问题所需之病例数和对照数能否得到?这样大小的样本能查出的最小相对危险度是多少?与估计的相差多少?[参考附录五(四)节]。 (5)病例来源及抽样技术明确否?病例数与对照数之比是多少?匹配否及匹配哪些变量?
24 54 115 (节录:Schlesselman,1982) 例:现拟进行一项病例对照调查,研究吸烟与肺癌的关系。预期吸烟者的相对危险度为10.0,人群吸烟率约0.4。设定α=0.05(双侧检验),β=0.10,查表可见至少需病例与对照各20。样本较小是因RR很大。如用公式(附式5-14)计算,得数也相近,(n≈22),稍
技术资料暂无技术资料 索取技术资料










